Impact of age at diagnosis on racial disparities in endometrial cancer patients

Gynecologic Oncology

Volumn 149, Issue 1, 2018, Pages 12-21

  Tarney, Christopher M ^a,b   Tian, Chunqiao ^a   Wang, Guisong ^a   Dubil, Elizabeth A ^a,b,c   Bateman, Nicholas W ^a,b   Chan, John K ^d   Elshaikh, Mohamed A ^e   Cote, Michele L ^f   Schildkraut, Joellen M ^g   Shriver, Craig D ^b   Conrads, Thomas P ^a,b,h   Hamilton, Chad A ^a,b   Maxwell, G Larry ^a,b,h,i   Darcy, Kathleen M ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^d PALO ALTO MEDICAL FOUNDATION   (United States)

^e HENRY FORD HOSPITAL   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h Inova Schar Cancer Institute   (United States)

ⁱ INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Age; Disparity; Endometrial cancer; Race; SEER; Survival

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; PTEN PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CARCINOSARCOMA; COHORT ANALYSIS; COPY NUMBER VARIATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL; UTERUS CANCER; BLACK PERSON; CANCER REGISTRY; CAUCASIAN; ENDOMETRIUM TUMOR; EPIDEMIOLOGY; ETHNOLOGY; GENETICS; HEALTH CARE DISPARITY; ONSET AGE; PATHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE OF ONSET; AGED; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MIDDLE AGED; PTEN PHOSPHOHYDROLASE; SEER PROGRAM; TUMOR SUPPRESSOR PROTEIN P53; UNITED STATES;

EID: 85027103255     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2017.07.145     Document Type: Article

References (43)

1. American Cancer Society, Cancer facts & figures. Atlanta: American Cancer Society. Available from https://www.cancer.org/cancer/endometrial-cancer/about/key-statistics.html, 2017.
2. Jemal, A., Siegel, R., Xu, J., Ward, E., Cancer statistics, 2010. CA Cancer J. Clin. 60:5 (2010), 277–300.
3. Long, B., Liu, F.W., Bristow, R.E., Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol. Oncol. 130:3 (2013), 652–659.
4. Farley, J., Risinger, J.I., Rose, G.S., Maxwell, G.L., Racial disparities in blacks with gynecologic cancers. Cancer 110:2 (2007), 234–243.
5. Cote, M.L., Ruterbusch, J.J., Olson, S.H., Lu, K., Ali-Fehmi, R., The growing burden of endometrial cancer: a major racial disparity affecting black women. Cancer Epidemiol. Biomark. Prev. 24:9 (2015), 1407–1415.
6. Randall, T.C., Armstrong, K., Differences in treatment and outcome between African-American and white women with endometrial cancer. J. Clin. Oncol. 21:22 (2003), 4200–4206.
7. Maxwell, G.L., Tian, C., Risinger, J., Brown, C.L., Rose, G.S., Thigpen, J.T. et al., Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma: a Gynecologic Oncology Group study. Cancer 107:9 (2006), 2197–2205.
8. Santin, A.D., Bellone, S., Siegel, E.R., Palmieri, M., Thomas, M., Cannon, M.J. et al., Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer. Am. J. Obstet. Gynecol. 192:3 (2005), 813–818.
9. Maxwell, G.L., Risinger, J.I., Hayes, K.A., Alvarez, A.A., Dodge, R.K., Barrett, J.C. et al., Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin. Cancer Res. 6:8 (2000), 2999–3005.
10. Elshaikh, M.A., Munkarah, A.R., Robbins, J.R., Laser, B.S., Bhatt, N., Cogan, C. et al., The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma. Gynecol. Oncol. 128:2 (2013), 171–174.
11. Allard, J.E., Chandramouli, G.V., Stagliano, K., Hood, B.L., Litzi, T., Shoji, Y. et al., Analysis of PSPHL as a candidate gene influencing the racial disparity in endometrial cancer. Front. Oncol., 2, 2012, 65.
12. Bateman, N.W., Dubil, E., Wang, G., Hood, B.L., Litzi, T., Oliver, J., Darcy, K.M., Hamilton, C.A., Conrads, T.P., Maxwell, G.L., Proteome and transcriptome alterations in black endometrial cancer patients correlate with poor disease outcome (ACCR abstract #5277). Proc. Amer. Assoc. Cancer Res. 58 (2017), 1351–1352.
13. Bateman, N.W., Dubil, E.A., Wang, G., Hood, B.L., Oliver, J.M., Litzi, T.A., Gist, G.D., Mitchell, D.A., Blanton, B., Phippen, N.T., Tian, C., Zahn, C.M., Cohn, D.E., Havrilesky, L.J., Berchuck, A., Shriver, C.D., Darcy, K.M., Hamilton, C.A., Conrads, T.P., Maxwell, G.L., Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer, 2017 Jun 27, 10.1002/cncr.30813 (Epub ahead of print) 28654152.
14. Dubil, E.A., Wang, T.G., Bateman, N.W., Levine, D.A., Conrads, T.P., Hamilton, C.A., Maxwell, G.L., Darcy, K.M., Racial differences in molecular subtypes between black and white patients with endometrial cancer (SGO abstract #8291). Gynecol. Oncol., 145(S1), 2017, 17.
15. Kohler, M.F., Berchuck, A., Davidoff, A.M., Humphrey, P.A., Dodge, R.K., Iglehart, J.D. et al., Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res. 52:6 (1992), 1622–1627.
16. Deligdisch, L., Holinka, C.F., Endometrial carcinoma: two diseases?. Cancer Detect. Prev. 10:3–4 (1987), 237–246.
17. Morrison, C., Zanagnolo, V., Ramirez, N., Cohn, D.E., Kelbick, N., Copeland, L. et al., HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients. J. Clin. Oncol. 24:15 (2006), 2376–2385.
18. Morrison, C., Miecznikowski, J., Darcy, K.M., Dolce, J.M., Kandel, E., Erwin, D.O. et al., A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome. Genes Chromosomes Cancer. 49:9 (2010), 791–802.
19. Aziz, H., Hussain, F., Edelman, S., Cirrone, J., Aral, I., Fruchter, R. et al., Age and race as prognostic factors in endometrial carcinoma. Am. J. Clin. Oncol. 19:6 (1996), 595–600.
20. Liu, J.R., Conaway, M., Rodriguez, G.C., Soper, J.T., Clarke-Pearson, D.L., Berchuck, A., Relationship between race and interval to treatment in endometrial cancer. Obstet. Gynecol. 86:4 Pt 1 (1995), 486–490.
21. Madison, T., Schottenfeld, D., James, S.A., Schwartz, A.G., Gruber, S.B., Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am. J. Public Health 94:12 (2004), 2104–2111.
22. Persson, I., Adami, H.O., Malker, B., Pettersson, B., Long-term survival in endometrial cancer with special reference to age as a prognostic factor. Ups. J. Med. Sci. 89:2 (1984), 159–170.
23. Oliver, K.E., Enewold, L.R., Zhu, K., Conrads, T.P., Rose, G.S., Maxwell, G.L. et al., Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment. Gynecol. Oncol. 123:1 (2011), 76–81.
24. Gayar, O.H., Robbins, J.R., Parikh, K., Lu, M., Buekers, T., Munkarah, A. et al., Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome. Gynecol. Oncol. 123:1 (2011), 71–75.
25. Vance, S., Yechieli, R., Cogan, C., Hanna, R., Munkarah, A., Elshaikh, M.A., The prognostic significance of age in surgically staged patients with type II endometrial carcinoma. Gynecol. Oncol. 126:1 (2012), 16–19.
26. Aziz, H., Rotman, M., Hussain, F., Smith, G., Chan, E., Choi, K. et al., Poor survival of black patients in carcinoma of the endometrium. Int. J. Radiat. Oncol. Biol. Phys. 27:2 (1993), 293–301.
27. Olson, S.H., Atoria, C.L., Cote, M.L., Cook, L.S., Rastogi, R., Soslow, R.A. et al., The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol. Biomark. Prev. 21:5 (2012), 753–760.
28. National Cancer Institute Department of Health and Human Services, SEER as a research resource. Available from https://seer.cancer.gov/about/factsheets/SEER_Research_Brochure.pdf, 2016.
29. Fritz, A.G., International Classification of Diseases for oncology: ICD-O. 3rd ed., vii, 2000, World Health Organization, Geneva (240 pp).
30. Broad Institute TCGA Genome Data Analysis Center, Analysis-ready standardized TCGA data from Broad GDAC Firehose stddata__2015_11_01 run., Broad Institute of MIT and Harvard http://dx.doi.org/10.7908/C1571BB1, 2016.
31. Cancer Genome Atlas Research, N., Kandoth, C., Schultz, N., Cherniack, A.D., Akbani, R., Liu, Y. et al., Integrated genomic characterization of endometrial carcinoma. Nature 497:7447 (2013), 67–73.
32. Hosmer, D.W., Lemeshow, S., Applied Logistic Regression. 2005, Wiley-Interscience, Hoboken, N.J.
33. Hosmer, D.W., Lemeshow, S., May, S., Applied Survival Analysis: Regression Modeling of Time-to-event Data. 2008, Wiley-Interscience, Hoboken, N.J.
34. Cote, M.L., Ruterbusch, J.J., Ahmed, Q., Bandyopadhyay, S., Alosh, B., Abdulfatah, E. et al., Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?. Gynecol. Oncol. 133:1 (2014), 38–42.
35. Wright, J.D., Fiorelli, J., Schiff, P.B., Burke, W.M., Kansler, A.L., Cohen, C.J. et al., Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer 115:6 (2009), 1276–1285.
36. Sherman, M.E., Devesa, S.S., Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 98:1 (2003), 176–186.
37. Plaxe, S.C., Saltzstein, S.L., Impact of ethnicity on the incidence of high-risk endometrial carcinoma. Gynecol. Oncol. 65:1 (1997), 8–12.
38. Robbins, H.A., Engels, E.A., Pfeiffer, R.M., Shiels, M.S., Age at cancer diagnosis for blacks compared with whites in the United States. J Natl Cancer Inst., 107(3), 2015.
39. Robbins, J.R., Gayar, O.H., Zaki, M., Mahan, M., Buekers, T., Elshaikh, M.A., Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer. Gynecol. Oncol. 131:3 (2013), 593–597.
40. Allard, J.E., Maxwell, G.L., Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control 16:1 (2009), 53–56.
41. Maxwell, G.L., Tian, C., Risinger, J.I., Hamilton, C.A., Barakat, R.R., Gynecologic Oncology Group S, Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?. Cancer 113:6 (2008), 1431–1437.
42. Clegg, L.X., Reichman, M.E., Hankey, B.F., Miller, B.A., Lin, Y.D., Johnson, N.J. et al., Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control 18:2 (2007), 177–187.
43. American Community Survey, US Census Bureau. Available from https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk.